Statins and prostate cancer prevention: where we are now, and future directions. (Q37187362)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Statins and prostate cancer prevention: where we are now, and future directions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Teemu J Murtola

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Jorma Lahtela

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Heimo Syvälä

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Teuvo Lj Tammela

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

10 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

published in

Nature Reviews Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

376-387

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

Peroxisome-proliferator-activated receptors and cancers: complex stories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

Latent carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Primary prevention trials: lessons learned about treating high-risk patients with dyslipidemia without known cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

The lipid and non-lipid effects of statins

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Statins and cancer prevention

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Statin induces apoptosis and cell growth arrest in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Lovastatin-induced RhoA modulation and its effect on senescence in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Atorvastatin and Celecoxib Inhibit Prostate PC-3 Tumors in Immunodeficient Mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Ras and Rho regulation of the cell cycle and oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Anti-inflammatory effects of statins: clinical evidence and basic mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Peroxisome Proliferator-Activated Receptors Mediate Pleiotropic Actions of Statins

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Long-term persistence in use of statin therapy in elderly patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

The Risk of Cancer in Users of Statins

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Statin use and cancer risk in the General Practice Research Database

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Cancer risk among statin users: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Statin use and the risk of breast and prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Statin use and the risk of 10 cancers.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Statin drugs and risk of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Statin use and risk of prostate cancer in the California Men's Health Study cohort

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Statins and prostate cancer risk: a case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Statins and cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Statins and risk of cancer: a systematic review and metaanalysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Long-term follow-up of the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Secondary prevention for patients following a myocardial infarction: summary of NICE guidance

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Changing trends of prostate cancer in Asia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Do statins affect androgen levels in men? Results from the Boston area community health survey

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Alterations of androgen receptor in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Pleiotropic effects of statins and related pharmacological experimental approaches

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Inflammation in prostate carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Hypertriglyceridemia as a possible risk factor for prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Active surveillance versus radical treatment for favorable-risk localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1146

7 January 2021

Identifiers

DOI

10.1038/NCPURO1146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18542103%20AND%20SRC:MED&resulttype=core&format=json